Zacks Investment Research upgraded shares of PHARMERICA CORP (PMC) from NEUTRAL to OUTPERFORM on May 22, 2012, with a target price of $11.40.
PharMerica Corporation is an institutional pharmacy services provider dedicated to providing quality customer service and innovative pharmacy solutions to institutional customers and patients in long-term care settings. PharMerica is a public company formed through the combination of the institutional pharmacy business of national healthcare services company Kindred Healthcare, Inc. and pharmaceutical services company AmerisourceBergen Corporation. As a result of this combination, PharMerica ranks as an industry-leading U.S. provider of institutional pharmacy services in terms of annual revenues.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on PHARMERICA CORP (PMC),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment